Although an efficient and commonly used method to introduce foreign genes into mammalian cells, retrovirusmediated gene transfer may lead to uncontrolled cell growth as a complication, caused by, for example, overexpression of introduced genes for growth or angiogenic factors and insertional mutagenesis. 1, 2 In addition, some transgenes are only effective when expressed at certain times. Therefore, it would be more appropriate if the transduced cells could be selectively eliminated after they have served their function or upon unwanted complications.
In cancer gene therapy, suicide genes encoding nonmammalian enzymes that convert relatively nontoxic prodrugs into highly toxic agents have been widely used. 3 An example is cytosine deaminase (CD; EC 3, 5, 4, 1) which catalyzes the deamination of cytosine to uracil 4 and converts the nontoxic compound 5-fluorocytosine (5FC) to the active chemotherapeutic agent 5-fluorouracil (5FU). 5 Therefore, CD-transfected cells commit metabolic suicide in the presence of 5FC in vitro and in vivo, [6] [7] [8] which can be exploited as a negative selection system. This system is not only useful in cancer treatment, but also has the potential of acting as a safeguard for other kinds of gene therapy.
The neomycin phosphotransferase gene (neo) as a positive selection marker is often included in retroviral vectors with a suicide gene for negative selection. However, in double-gene vectors, the expression of a transgene may be influenced by the neo gene. 9, 10 Selection for expression
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Received 24 April 1998; accepted 19 June 1998 of one gene often causes a significant reduction in the expression of the unselected gene, 11 and the excision of the neo gene from a retroviral vector in transduced cells increases transgene expression driven by the retroviral promoter.
12 It may be desirable to use a suicide gene such as the CD gene as both a positive and negative selectable marker in a single gene system. In these vectors, a second nonselectable gene may be coexpressed with a suicide gene without a positive selection marker, hence it is favorable to use only a suicide gene with both positive and negative selection functions to enable growth manipulation of genetically modified cells. A suicide retroviral vector (pRUFCD) was constructed to explore its potential for both selection systems. It contains the E. coli CD gene controlled by the rat ␤-actin promoter to allow for positive and negative selections, and a polycloning site for insertion and expression of transgene under the control of the Moloney murine leukemia virus (MoMLV) 5Ј long terminal repeat (LTR) (Figure 1) .
The dose-response curves of parental CRE retroviral packaging cells and MBT-2 murine bladder tumor cells to 5FU or 5FC were determined using the thymidine incorporation assay 5 or 6 days after treatment. Their sensitivities to 5FU and 5FC varied. The minimal concentration required for maximal cell death was determined as 0.4 m of 5FU and thus was used in the positive selection medium. In addition, cytotoxic effects were seen in these cells at high 5FC concentrations, with the IC 50 values (concentration of drug producing 50% inhibition of cell growth) for 5FC in CRE and MBT-2 cells being 500 m and 700 m, respectively. We employed 5FU and cytosine in selection medium to screen for cells expressing CD. Data for positive selection in Figure 2 show that into the multiple cloning site of p6J⍀. 20 The
plasmid pSPCD was obtained by inserting the 2.5-kb HpaI-PvuII fragment of pACD into the EcoRV site of pSP72 (Promega, Madison, WI, USA). To construct a retroviral vector containing the CD gene without the neo gene, the 2.5-kb BglIIClaI fragment was isolated from pSPCD and used to replace the BamHIClaI fragment containing the neo module of pRUFneo. 21 The resulting plasmid pRUFCD contains eukaryotic expression elements: MoMLV 5Ј LTR promoter, polycloning site, rat ␤-actin promoter, CD gene, intervening sequence (IVS) of SV40 t-antigen and MoMLV 3Ј LTR promoter.
three CD-transfected cell clones, CRECD1, CRECD2 and CRECD3, chosen at random from 23 CD-transfected clones isolated under the positive selection scheme, were less sensitive to 5FU toxicity in the presence of 100 m of cytosine compared with its wild-type counterpart. The survival of CD-positive cells was approximately 30-40%, which may be due to the high cytotoxic effect of 5FU being only partially relieved by cytosine. In our positive selection scheme, cells were placed in selection medium for 7 days, since parental cells and mock-transfected controls died completely after 5-6 days of selection and CDpositive cells became susceptible to 5FU toxicity if the selection medium was used for longer than 10 days. The known competition between pyrimidine bases for metabolic enzymes and the similar Michaelis constant of dihydropyrimidine dehydrogenase, the degradation enzyme of uracil and 5FU, 13 suggest that the mechanism by which cytosine relieves 5FU toxicity in CD-expressing cells is through competitive inhibition of 5FU metabolism by uracil converted from cytosine.
A positive selection procedure for CD gene has been previously described which uses N-(phosphonacetyl)-laspartate (PALA), cytosine and inosine in the selection medium.
14 As the de novo synthesis of UMP is blocked by PALA, only the pathway provided by the transfected CD allows for UMP formation through uracil converted from cytosine. Inosine was thought to increase uracil uptake and form the basis for effective positive selection in the above pathway. However, it has been reported that the uptake of uracil was insufficient to support cell proliferation even with inosine enhancement in PALA- treated Novikoff hepatoma cells, since the intracellular level of ribose-1-phosphate plays a rate-limiting role in this pathway. 15 Thus, the positive selection for cytosine conversion in the presence of PALA and inosine might not be appropriate in some cell types.
Two CD-transfected CRE cell clones positively selected for CD and their parental or vector-control cells were subsequently tested for ability to be negatively selected. As shown in Figure 3 , the cell survival of CD-transfected CRE cells was less than 5% under 5FC (500 m) treatment compared with the control cells with more than 90% survival. These data support the idea of using the positive selection scheme to isolate CD transfectants for subsequent negative selection. The retrovirus-containing supernatant collected from CD-transfected CRE cells was used to transduce MBT-2 cells. As shown in Figure  4 , two CD-transduced cell clones, MBT-2/CD1 and MBT-2/CD2, chosen at random from 16 CD-transduced clones isolated under the positive selection scheme were less sensitive to 5FU toxicity in the presence of 200 m of cytosine compared with its wild-type counterpart. However, 5FC sensitivity was dramatically increased in CDtransduced MBT-2 cells as the IC 50 value for 5FC shifted from approximately 700 m in parental MBT-2 cells to approximately 1.2 m in MBT-2/CD cells. It has been shown that the IC 50 value for 5FC in WiDr cells, a human colorectal tumor cell line, shifted from 26 000 m in parental cells to 27 m in CD-expressing cells, 16 whereas for rat glioma C6 cells it altered from 6000 m in CD-nega- tive to 3 m in CD-positive C6 cells. 17 The difference in the IC 50 value of 5FC between distinct cell types may be caused by variation in their 5FC permeabilities 18 and CD expression levels of transfectants. Our results also demonstrated that CD-transduced tumor cells positively selected in vitro with 5FU and cytosine showed susceptibility to 5FC in subsequent negative selection both in MBT-2 mouse bladder tumor and B16F10 mouse melanoma tumor models (data not shown).
The advantages of the CD-5FC enzyme-prodrug system over other negative selection systems such as herpes simplex virus thymidine kinase (HSVtk) include lack of interference by host endogenous enzyme, lack of toxicity observed with the prodrug 5FC, and the higher bystander effect. 7, 19 Therefore, the bacterial CD gene providing both positive and negative selections is a useful tool in gene therapy. By acting as a positive selection marker in combination with cytosine and 5FU, cells carrying a vector encoding this gene can be easily selected and manipulated in vitro. Furthermore, as a nonselectable therapeutic transgene can be coexpressed with the CD gene in the vector, the transduced cells can be eliminated in vivo through the negative selection process to avoid uncontrolled complications after the transgene has furnished its effects.
